About Us

Combination Therapies that Expand the Power of Human Immunity

Partnerships are a core component of our business growth and diversification strategy, and we have established a diverse portfolio of collaborations with pharmaceutical and biotech companies, government organizations and research institutes. These relationships have enabled us to accelerate the rate of development in our pipeline, as well as to increase the number of product candidates across a wide variety of applications

We are committed to building long-term relationship by aligning our interests with those of our partners, and have accumulated a strong track record of successful collaborations. We are focused on building value for all parties, with the goal of bringing new options to market in areas of significant unmet medical needs.

We are actively seeking partnership opportunities with our lead immuno-oncology candidate, DPX-Survivac, to assess novel combinations in areas of high, unmet medical needs, as well as further clinical development in ovarian cancer and other cancers. We also seek opportunities to deploy our candidate products via licensing collaborations in other hard-to-treat disease areas.

We invite you to submit business development proposals or inquiries about collaborating with IMV using the form below.

Please note that any proposals that are submitted to IMV via email or via our website will be considered non-confidential. No information exchange may be deemed confidential without a signed confidentiality or disclosure agreement from IMV.

High Standards. Even Higher Aspirations.

Working at IMV brings you to the forefront of cutting-edge science and research for cancer and other serious diseases. We’ve worked hard to build a culture of innovation and collaboration.

Learn more about life at IMV